Lenalidomide (Revlimid™), bortezomib (Velcade™), and dexamethasone, are used alone or in combination (RVd therapy) as first-line therapies for hematologic malignancies including the plasma cell dyscrasia, Multiple Myeloma (MM). The effects of RVd treatment on tumor cells have been documented, but little is known about...
Lucas T. Graybuck, L. Okada, Wei-Ling Chang et al.· bioRxiv· 0 citations
Peripheral blood mononuclear cells (PBMCs) are commonly used for immune profiling in clinical research, but their isolation and cryopreservation present logistical challenges, particularly in settings with limited access to research facilities. To address this, we implemented a whole blood fixation protocol to preserve...
V. Parthasarathy, A. Heubeck, Tyanna J. Stuckey et al.· Cytometry Part A· 0 citations
A large-scale scATAC-seq resource that substantially improves immune cell annotation and regulatory inference and provides an unprecedented reference for immune cell gene regulatory circuits and a valuable resource for exploring the epigenome of human immune cells is presented.
Sydney Kuhl, Upaasana Krishnan, Andreas Tjaernberg et al.· Journal of Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.